Position in INVA
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$4,778,177
+$1,073,651 QoQ
Shares Held
205,072
+10.7% QoQ
Ownership
0.278%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ASSETMARK, INC holds $266,175,967 across 93 Biotechnology names. INVA ranks #10 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
3,388,920 | $145,350,778 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
59,954 | $26,771,859 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
166,617 | $10,768,456 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,316 | $9,515,834 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
29,569 | $8,781,105 | |
| 6 | ARGX |
Argenx SE
|
9,275 | $6,773,068 | |
| 7 | GMAB |
Genmab A/S
|
224,144 | $6,013,783 | |
| 8 | INSM |
INSMED Inc
|
34,258 | $5,601,868 |
All Filings in INVA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,778,177 | 205,072 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $3,704,526 | 185,319 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $3,253,993 | 178,301 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,262,575 | 162,398 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $3,161,654 | 174,388 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,895,350 | 166,879 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,990,925 | 154,890 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $2,422,640 | 147,722 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,148,337 | 140,967 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $913,301 | 56,939 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $711,267 | 54,755 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $671,456 | 52,746 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $599,557 | 53,294 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $532,040 | 40,154 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $516,935 | 44,525 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $1,447,587 | 98,075 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $1,707,966 | 88,267 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,523,295 | 88,307 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,284,013 | 76,841 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $936,822 | 69,860 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $739,095 | 61,849 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $565,145 | 45,613 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $399,357 | 38,216 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $164,111 | 11,739 | Shares | Sole | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||